Listen "Will the price for Ozempic ever go down?"
Episode Synopsis
The “miracle drug”, aka GLP-1 or Ozempic, swept the world with a solution for weight loss and to fight diabetes. But now, after all that hype, the patents are about to expire, and the prices are too high. Are healthcare investors fearing that profits might be dropping to zero? And with elections right around the corner, what are the candidates saying about imposing price gaps?
More episodes of the podcast UBS Trending
US economy: A tale of resilience
02/12/2025
Emerging Market 2026 expectations
28/11/2025
Housing market in motion
26/11/2025
Fixed income outlook
24/11/2025
The future of giving
21/11/2025
Reading the economic room
19/11/2025
Making sense of Fed moves and markets
18/11/2025
Credit moves and mortgage rate lows
14/11/2025
Economic crossroads with Dr. David Kelly
13/11/2025
Business minded, market ready
05/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.